News
IBD biologics, other therapies cleared of causing major adverse cardiovascular events
Biologics infliximab, adalimumab, golimumab, certolizumab, vedolizumab, natalizumab, and ustekinumab not only did not increase risk, but they...
News
Two multitarget stool tests show promise for CRC screening: Studies
"This is the first large study to include the 45- to 49-year-old population, for whom screening is now recommended."
News
GLP-1 agonists linked to higher risk for rare but serious GI complications
Investigators say their findings are not about scaring people off the weight-loss drugs, but instead about increasing awareness that these...
News
Five questions for COVID experts: How concerned should we be?
“A challenge with COVID-19, all along, has been disparities in access to care, and this will be worse without public support for prevention and...
News
It may be time to pay attention to COVID again
While the numbers are still low, compared with 2022’s summer surge, experts still urge people to stay aware of changes in the virus. “I do not...
News
Experts highlight benefits and offer caveats for first postpartum depression pill
“A fast-acting pill that can be taken orally could be an ideal option for the 15% to 20% of women who experience postpartum depression.”
News
How newly discovered genes might fit into obesity
Although the study is not the first to point to specific genes, “we were quite surprised by the proposed function of some of the genes we...
News
ChatGPT in medicine: The good, the bad, and the unknown
Three-expert panel at DDW suggests clinicians should embrace the technology.
News
Etrasimod looks safe for ulcerative colitis out to 2.5 years
If approved by the FDA, etrasimod could become the second agent in the S1P class approved for ulcerative colitis in the United States.
News
Wildfire smoke and air quality: How long could health effects last?
The effects of smoke from wildfires can continue for many years.
News
Can a saliva test predict the best way to manage obesity?
“We still don’t have randomized trials where we’re looking at obesity phenotyping yet.”
News
At-home monitoring device can predict Crohn’s disease flares
A new device developed at Massachusetts Institute of Technology shows promise.
News
Fewer discontinuations with infliximab vs. vedolizumab for UC maintenance therapy
Findings are based on a pooled analysis of six randomized controlled trials from the past 10 years.
News
Endoscopic sleeve gastroplasty plus obesity drugs add up to more weight loss
Some experts believe weight-loss medications can help with the rebound in weight that some people experience months after bariatric surgery.
News
Gray hair and aging: Could ‘stuck’ stem cells be to blame?
New evidence points to a cycle wherein undifferentiated stem cells mature to perform their hair-coloring duties and then transform back to their...